Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.48 -0.01 (-2.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Change in Accured Expenses (2021 - 2026)

Updated

Pasithea Therapeutics' Change in Accured Expenses was $348,432 in Q2 2026, up 36.3% from $255,576 a year earlier but down 2.8% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Change in Accured Expenses (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Pasithea Therapeutics' Change in Accured Expenses was $256,416 through Jun 30, 2026, up 37.4% year-over-year; for FY2025, it came in at $11,233.

  • Change in Accured Expenses shows a five-year compound annual growth rate of 11.2% (FY2020 to FY2025).
  • In earlier years, Change in Accured Expenses was -$1.43 million in FY2024, $1.07 million in FY2023 (+43.6%), $745,759 in FY2022 (+69.2%) and $440,677 in FY2021.
  • Quarterly Change in Accured Expenses has moved between -$1.04 million (Q2 2024) and $682,903 (Q4 2023) over five years.
  • Per Business Quant data, KTTA's Change in Accured Expenses in the three quarters before Q2 2026 was $358,381 (Q1 2026), -$206,697 (Q4 2025) and -$243,700 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Pasithea Therapeutics 16.04 Mn 16.04 Mn - 348,432.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 348,432.00
Mar 31, 2026 358,381.00
Dec 31, 2025 -206,697.00
Sep 30, 2025 -243,700.00
Jun 30, 2025 255,576.00
Mar 31, 2025 206,054.00
Dec 31, 2024 483,373.00
Sep 30, 2024 -758,354.00
Jun 30, 2024 -1.04 Mn
Mar 31, 2024 -118,369.00
Dec 31, 2023 682,903.00
Sep 30, 2023 -45,339.00
Jun 30, 2023 467,258.00
Mar 31, 2023 -33,855.00
Dec 31, 2022 280,153.00
Sep 30, 2022 405,669.00
Jun 30, 2022 30,384.00
Mar 31, 2022 29,553.00
Dec 31, 2021 -80,816.00
Sep 30, 2021 73,415.00
API Access

Pasithea Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=KTTA&period=max&api_key=YOUR_API_KEY